Minnesota recalls

Baxter Healthcare Corporation is recalling one lot of Vancomycin Injection (NDC 0338-3583-01, Lot #NC193894) due to deviations from good manufacturing practices (CGMP). The affected lot was distributed nationwide in the US, Puerto Rico, and Chile.

Baxter Healthcare Corporation is recalling three lots of Vasopressin injection due to manufacturing process deviations that do not meet FDA quality standards. The affected lots were distributed nationwide, in Puerto Rico, and Chile. No injuries have been reported.

Baxter Healthcare Corporation is recalling one lot of Clindamycin Injection USP in 5% Dextrose due to deviations from manufacturing quality standards. The affected lot was distributed nationwide, in Puerto Rico, and Chile.

Baxter Healthcare Corporation is recalling one lot of Clindamycin Injection USP in 5% Dextrose (900 mg/50 mL) due to deviations from current good manufacturing practices (CGMP). The affected lot was distributed nationwide, in Puerto Rico, and Chile. No injuries have been reported.

Baxter Healthcare Corporation is recalling a specific lot of Clindamycin Phosphate in 0.9% Sodium Chloride Injection due to deviations from current Good Manufacturing Practice (CGMP) standards during production. The affected lot (NC193689, expiring 10/16/2027) was distributed nationwide, as well as to Puerto Rico and Chile.

Baxter Healthcare has recalled three specific lots of Clindamycin Injection USP (900 mg per 50 mL) due to deviations from Good Manufacturing Practice (CGMP) standards during production. The affected lots were distributed nationwide, Puerto Rico, and Chile. No injuries have been reported.

Baxter Healthcare has recalled multiple lots of Nexterone (amiodarone HCI) injection due to deviations from good manufacturing practices (CGMP) during production. The affected lots were distributed nationwide, Puerto Rico, and Chile. No injuries have been reported.

Baxter Healthcare has recalled specific lots of CARDENE IV (nicardipine hydrochloride) injection due to deviations from manufacturing quality standards. The affected lots were distributed in the United States, Puerto Rico, and Chile.

Baxter Healthcare Corporation is recalling one lot of Pantoprazole Sodium in 0.9% Sodium Chloride Injection due to deviations from current good manufacturing practices (CGMP). The affected lot was distributed in the United States, Puerto Rico, and Chile.

Baxter Healthcare is recalling specific lots of Vasopressin injection due to deviations from manufacturing standards (CGMP). The affected lots may not meet required quality and purity standards. This is a precautionary recall of a medication used in hospitals and clinical settings.

Baxter Healthcare Corporation is recalling specific lots of dexmedetomidine hydrochloride injection due to deviations from current good manufacturing practice (CGMP) standards during production. The affected lots were distributed nationwide, in Puerto Rico, and Chile.

Baxter Healthcare is recalling two lots of famotidine injection (20 mg in 50 mL sodium chloride) due to deviations from manufacturing standards. The affected lots may not meet quality and sterility requirements.

Baxter Healthcare Corporation is recalling specific lots of Clindamycin Injection USP in 5% Dextrose due to deviations from current Good Manufacturing Practice (CGMP) standards during production. The affected lots are NC193764 (expiration 10/18/2027) and NC195232 (expiration 11/25/2027), distributed nationwide in the US, Puerto Rico, and Chile.

Baxter Healthcare is recalling one lot of Daptomycin in 0.9% Sodium Chloride Injection due to deviations from good manufacturing practices (CGMP) during production. The affected lot (NC188692, expiring 11/22/2027) was distributed nationwide, in Puerto Rico, and Chile. No injuries have been reported.

Baxter Healthcare is recalling specific lots of MYXREDLIN (insulin human injection) due to deviations from current Good Manufacturing Practice (CGMP) standards during production. The affected lots were distributed in the US, Puerto Rico, and Chile. No injuries have been reported.

Baxter Healthcare Corporation is recalling five lots of Vancomycin Injection USP in 5% Dextrose due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing. The affected lots were distributed nationwide, in Puerto Rico, and Chile.

Golden State Medical Supply Inc. is recalling Prasugrel HCI 10mg tablets (lot GS062298, expiration 09/30/2026) because they failed to meet dissolution specifications during quality testing. Dissolution is how quickly a tablet breaks down in the body to release its active ingredient. Tablets that dissolve too slowly or incompletely may not work as intended.

Food to Live Organic SuperGrass Powder in 6 oz, 12 oz, 1 lb, and 4 lb containers has been recalled due to Salmonella contamination. The affected products were distributed across the United States and U.S. Virgin Islands. No illnesses have been reported.

BMC Medical Co., Ltd. recalled 20,160 Luna G3 APAP sleep apnea devices (Model LG3600) due to a firmware defect in version G3-2.00.76. Under certain high-pressure, high-breathing-rate conditions, affected devices can display an error message and shut down automatically, stopping therapy delivery. Most devices were corrected with a firmware upgrade, but up to 196 units may still contain the defective version.

Foods Alive Inc is recalling 8-ounce packages of organic moringa leaf powder because they may be contaminated with Salmonella. The contamination was discovered after the supplier's sample tested positive. No illnesses have been reported so far.

SUPPLX.com's Business Pill and Branch Manager for Men dietary supplements contain yohimbine that is not listed on the labels. FDA testing found dangerously high levels of this substance, which can cause serious heart problems, severe high blood pressure, and other dangerous side effects—especially in people taking stimulants or certain medications.

American Regent is recalling three lots of epinephrine injection (1 mg/mL multi-dose vials) due to leaking and cracked vials, plus contamination with particles including nylon, cellulosic, acrylic, polyethylene, and glass. These particles can block blood vessels, cause blood clots, and damage organs; cracked vials also risk loss of sterility and bacterial contamination. No adverse events have been reported so far.

Certain Mondraker mountain bicycles equipped with ONOFF S9 Carbon MTB handlebars may have handlebars that crack or fracture during use. This can cause loss of control and a fall. The company has received five reports of handlebar breakage, including two injuries from falls.

Clorox Puerto Rico is recalling about 6.3 million bottles of scented Mistolin and Lestoil cleaners sold in Puerto Rico and the U.S. Virgin Islands. The products may contain Pseudomonas aeruginosa bacteria, which can cause serious infections in people with weakened immune systems or external medical devices if the bacteria is inhaled, touches the eyes, or enters through a break in the skin. People with healthy immune systems are typically unaffected.

The lithium-ion battery in XO Poppy Power Trip Magnetic Wireless Power Banks (model PYPBK5M) can overheat and catch fire. About 32,400 units were sold at TJX and Marshalls stores in three colors: cream, cream with pink bow print, and black with teddy bear print. No injuries have been reported.

The black eyes on this teether can detach when frozen, creating a choking risk for babies. Skip Hop has received four reports of eyes coming off, though no injuries have been reported yet.

These squishy toys contain water beads that can expand if swallowed, potentially causing choking, intestinal blockage, and serious injury or death. The toys are translucent squishy balls with cartoon faces, sold in tan bamboo steamer-shaped containers.

OKK Trading's Rainbow Mystery Squishy Bun Toys contain water beads that can expand larger than safe limits. If a child swallows a water bead, it can cause choking, intestinal blockage, and serious injury or death.

Gizoon Direct six-drawer dressers can tip over if not anchored to the wall, creating a risk of serious injury or death to children. The dressers do not meet federal safety standards for furniture stability.

The backrests on certain Branch height-adjustable ergonomic chairs can detach due to incorrectly installed anchors at the factory. This poses a fall hazard. The chairs were made between September 10, 2025 and April 22, 2026. Branch has received 11 reports of backrest detachment but no injuries so far.